Literature DB >> 3017502

Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord.

K Tsou, H Khachaturian, H Akil, S J Watson.   

Abstract

A dispersed descending pro-opiomelanocortin (POMC) fiber system has been demonstrated by peroxidase-antiperoxidase (PAP) immunocytochemistry in the adult rat spinal cord. beta-endorphin, adrenocorticotrophic hormone (ACTH), alpha-melanocyte-stimulating hormone (alpha-MSH) and 16K immunoreactive fibers exist in the spinal cord from cervical down to sacral level. Descending fibers running parallel in the dorsolateral and lateral funiculus send collaterals ventromedially or medially to terminate in the gray matter surrounding the central canal, where nociceptive neurons have recently been located, in addition to those nociceptive cells in the dorsal horn. After spinal transection at lower thoracic level, POMC peptide immunoreactivities disappeared below the lesion. Moreover, no POMC cell bodies were found in the spinal cord. Therefore, the descending fibers are most likely of supraspinal origin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017502     DOI: 10.1016/0006-8993(86)90283-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Melanocortin-4 receptor expression in different classes of spinal and vagal primary afferent neurons in the mouse.

Authors:  Laurent Gautron; Charlotte E Lee; Syann Lee; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

2.  Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.

Authors:  Lijun Lao; Bingbing Song; Wenling Chen; Juan Carlos G Marvizón
Journal:  Brain Res       Date:  2008-01-03       Impact factor: 3.252

3.  Inhibition of spinal opioid antinociception by intrathecal beta-endorphin1-27 in the rat.

Authors:  M Hong; M Sutak; K Jhamandas
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.

Authors:  D H Vrinten; W H Gispen; G J Groen; R A Adan
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

5.  Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor.

Authors:  Mahmoud Mansour; Doug White; Catherine Wernette; John Dennis; Ya-Xiong Tao; Robert Collins; Lauren Parker; Edward Morrison
Journal:  Endocrine       Date:  2010-01-07       Impact factor: 3.633

Review 6.  Endogenous opioids and excessive alcohol consumption.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

7.  Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.

Authors:  Juan Carlos G Marvizón; Wenling Chen; Niall Murphy
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

8.  Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors.

Authors:  J C G Marvizón; O A Pérez; B Song; W Chen; N W Bunnett; E F Grady; A J Todd
Journal:  Neuroscience       Date:  2007-07-05       Impact factor: 3.590

9.  Effects of veratridine and high potassium on micro-opioid receptor internalization in the rat spinal cord: stimulation of opioid release versus inhibition of internalization.

Authors:  Wenling Chen; Bingbing Song; Guohua Zhang; Juan Carlos G Marvizón
Journal:  J Neurosci Methods       Date:  2008-03-10       Impact factor: 2.390

10.  Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.

Authors:  Wenling Chen; Bingbing Song; Lijun Lao; Orlando A Pérez; Woojae Kim; Juan Carlos G Marvizón
Journal:  Neuropharmacology       Date:  2007-08-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.